These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37610876)

  • 1.
    Malisova L; Vrbova I; Pomorska K; Jakubu V; Zemlickova H
    Microb Drug Resist; 2023 Oct; 29(10):485-491. PubMed ID: 37610876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
    Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A
    Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro Activity of Cefiderocol and Ceftazidime-Avibactam, Against Carbapenemase-Producing Enterobacterales.
    Ozyurt OK; Tufanoglu P; Cetinkaya O; Ozhak B; Yazisiz H; Ongut G; Turhan O; Ogunc D
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Carbapenemase Encoding Gene and Resistance to Cefiderocol in Hospital and Community eXtensive Drug Resistance and Carbapenem-Resistant
    Benzaarate I; El Otmani F; Khazaz A; Timinouni M; Bourjilat F; Bogaerts P; Huang TD; Nayme K
    Foodborne Pathog Dis; 2023 Oct; 20(10):460-466. PubMed ID: 37616567
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
    Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
    Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology of carbapenem-resistant gram-negative bacilli in Ecuador.
    Soria-Segarra C; Soria-Segarra C; Molina-Matute M; Agreda-Orellana I; Núñez-Quezada T; Cevallos-Apolo K; Miranda-Ayala M; Salazar-Tamayo G; Galarza-Herrera M; Vega-Hall V; Villacis JE; Gutiérrez-Fernández J
    BMC Infect Dis; 2024 Apr; 24(1):378. PubMed ID: 38582858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
    Rizek C; Fu L; Dos Santos LC; Leite G; Ramos J; Rossi F; Guimaraes T; Levin AS; Costa SF
    Ann Clin Microbiol Antimicrob; 2014 Sep; 13():43. PubMed ID: 25179208
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wise MG; Karlowsky JA; Hackel MA; Takemura M; Yamano Y; Echols R; Sahm DF
    Microb Drug Resist; 2023 Aug; 29(8):360-370. PubMed ID: 37253158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity.
    Gill CM; Santini D; Nicolau DP;
    J Antimicrob Chemother; 2024 Feb; 79(2):412-416. PubMed ID: 38153232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of phenotypic methods and polymerase chain reaction for the detection of carbapenemase production in clinical Klebsiella pneumoniae isolates].
    Tekintaş Y; Çilli F; Eraç B; Yaşar M; Aydemir SŞ; Hoşgör Limoncu M
    Mikrobiyol Bul; 2017 Jul; 51(3):269-276. PubMed ID: 28929963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey.
    Malkoçoğlu G; Aktaş E; Bayraktar B; Otlu B; Bulut ME
    Microb Drug Resist; 2017 Apr; 23(3):328-334. PubMed ID: 27326514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital.
    Weber C; Schultze T; Göttig S; Kessel J; Schröder A; Tietgen M; Besier S; Burbach T; Häussler S; Wichelhaus TA; Hack D; Kempf VAJ; Hogardt M
    Microbiol Spectr; 2022 Oct; 10(5):e0169722. PubMed ID: 36190424
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Shortridge D; Streit JM; Mendes R; Castanheira M
    Microbiol Spectr; 2022 Apr; 10(2):e0271221. PubMed ID: 35262394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
    Delgado-Valverde M; Conejo MDC; Serrano L; Fernández-Cuenca F; Pascual Á
    J Antimicrob Chemother; 2020 Jul; 75(7):1840-1849. PubMed ID: 32277821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of Cefiderocol Against
    Iregui A; Khan Z; Landman D; Quale J
    Microb Drug Resist; 2020 Jul; 26(7):722-726. PubMed ID: 32031915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant
    Shortridge D; Kantro V; Castanheira M
    Microbiol Spectr; 2023 Feb; 11(1):e0450722. PubMed ID: 36622238
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Guo Y; Han R; Jiang B; Ding L; Yang F; Zheng B; Yang Y; Wu S; Yin D; Zhu D; Hu F;
    Microbiol Spectr; 2022 Aug; 10(4):e0185422. PubMed ID: 35862963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.
    Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of carbapenemases bla
    Haider MH; McHugh TD; Roulston K; Arruda LB; Sadouki Z; Riaz S
    Ann Clin Microbiol Antimicrob; 2022 May; 21(1):18. PubMed ID: 35590320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of carbapenem-resistant Enterobacterales isolates to new antibiotics from a tertiary care hospital, Egypt: A matter of hope.
    Badran SG; Malek MM; Ateya RM; Afifi AH; Magdy MM; Elgharabawy ES
    J Infect Dev Ctries; 2022 Dec; 16(12):1852-1859. PubMed ID: 36753651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.